{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T15:54:55Z","timestamp":1770134095578,"version":"3.49.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,3]],"date-time":"2017-06-03T00:00:00Z","timestamp":1496448000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Argentina de Microbiolog\u00eda"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.ram.2017.02.008","type":"journal-article","created":{"date-parts":[[2017,9,15]],"date-time":"2017-09-15T18:45:42Z","timestamp":1505501142000},"page":"332-338","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["In vitro anti-tuberculosis activity of azole drugs against Mycobacterium tuberculosis clinical isolates"],"prefix":"10.1016","volume":"49","author":[{"given":"Bel\u00e9n R.","family":"Imperiale","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1ngel A.","family":"Cataldi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nora S.","family":"Morcillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ram.2017.02.008_bib0165","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1574-6968.2006.00224.x","article-title":"The potential of azole antifungals against latent\/persistent tuberculosis","volume":"258","author":"Ahmad","year":"2006","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.ram.2017.02.008_bib0170","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.femsle.2005.07.022","article-title":"In vitro and ex vivo antimycobacterial potential of azole drugs against Mycobacterium tuberculosis H37Rv","volume":"251","author":"Ahmad","year":"2005","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.ram.2017.02.008_bib0175","doi-asserted-by":"crossref","first-page":"3903","DOI":"10.1128\/AAC.00753-13","article-title":"Efficacy and safety of metronidazole for pulmonary multidrug-resistant tuberculosis","volume":"57","author":"Carroll","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ram.2017.02.008_bib0180","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1128\/AAC.33.6.963","article-title":"Sputum levels of fluconazole in humans","volume":"33","author":"Ebden","year":"1989","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ram.2017.02.008_bib0185","first-page":"285","article-title":"Mechanisms of selective toxicity of metronidazole and other nitroimidazole drugs","volume":"56","author":"Edwards","year":"1980","journal-title":"Br J Vener Dis"},{"key":"10.1016\/j.ram.2017.02.008_bib0190","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1128\/AAC.01736-09","article-title":"Activity of drug combinations against dormant M. tuberculosis","volume":"54","author":"Filippini","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ram.2017.02.008_bib0195","series-title":"Antibiotics in laboratory medicine","first-page":"938","article-title":"Extravascular antimicrobial distribution in man","author":"Gerding","year":"1986"},{"key":"10.1016\/j.ram.2017.02.008_bib0200","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.toxlet.2010.07.005","article-title":"Are azole fungicides a teratogenic risk for human conceptus?","volume":"198","author":"Giavini","year":"2010","journal-title":"Toxicol Lett"},{"key":"10.1016\/j.ram.2017.02.008_bib0205","series-title":"Global Tuberculosis report","first-page":"54","year":"2014"},{"key":"10.1016\/j.ram.2017.02.008_bib0210","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.tube.2003.08.003","article-title":"M. tuberculosis persistence, latency and drug tolerance","volume":"1","author":"Gomez","year":"2004","journal-title":"Tuberculosis"},{"key":"10.1016\/j.ram.2017.02.008_bib0215","doi-asserted-by":"crossref","first-page":"e75245","DOI":"10.1371\/journal.pone.0075245","article-title":"Identification of new drug targets and resistance mechanisms in Mycobacterium tuberculosis","volume":"8","author":"Ioerger","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ram.2017.02.008_bib0220","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1128\/AAC.01468-06","article-title":"Metronidazole plus rifampin sterilizes long-term dormant M. tuberculosis","volume":"51","author":"Iona","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ram.2017.02.008_bib0225","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2165\/00003088-199936050-00004","article-title":"Pharmacokinetics and pharmacodynamics of the nitroimidazole antimicrobials","volume":"36","author":"Lamp","year":"1999","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.ram.2017.02.008_bib0230","doi-asserted-by":"crossref","first-page":"e211","DOI":"10.1371\/journal.pbio.0050211","article-title":"Nitroimidazole action in Entamoeba histolytica: a central role for thioredoxin reductase","volume":"5","author":"Leitsch","year":"2007","journal-title":"PLoS Biol"},{"key":"10.1016\/j.ram.2017.02.008_bib0235","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0378-1097(00)00071-9","article-title":"Phospholipid and sterol analysis of plasma membranes of azole-resistant Candida albicans strains","volume":"185","author":"L\u00f6ffler","year":"2000","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.ram.2017.02.008_bib0240","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S1471-4914(02)02280-3","article-title":"Molecular basis of resistance to azole antifungals","volume":"8","author":"Lupetti","year":"2002","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.ram.2017.02.008_bib0245","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1099\/00221287-148-10-2937","article-title":"Azole antifungals are potent inhibitors of cytochrome P450 mono-oxygenases and streptomycetes","volume":"148","author":"Mc Lean","year":"2002","journal-title":"Microbiology"},{"key":"10.1016\/j.ram.2017.02.008_bib0250","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.abb.2007.03.026","article-title":"Structure, function and drug targeting in Mycobacterium tuberculosis cytochrome P450 systems","volume":"464","author":"McLean","year":"2007","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.ram.2017.02.008_bib0255","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.tim.2006.03.002","article-title":"The preponderance of P450s in the Mycobacterium tuberculosis genome","volume":"14","author":"McLean","year":"2006","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.ram.2017.02.008_bib0260","doi-asserted-by":"crossref","first-page":"5524","DOI":"10.1016\/j.ejmech.2011.09.013","article-title":"Synthesis and biological activities of triazole derivatives as inhibitors of InhA and antituberculosis agents","volume":"46","author":"Menendez","year":"2011","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.ram.2017.02.008_bib0265","first-page":"1169","article-title":"Evaluation of MGIT960 and the colorimetric based method for tuberculosis drug susceptibility testing","volume":"14","author":"Morcillo","year":"2010","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ram.2017.02.008_bib0270","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.4155\/fmc.11.90","article-title":"Nitroimidazoles for the treatment of TB: past, present and future","volume":"3","author":"Mukherjee","year":"2011","journal-title":"Future Med Chem"},{"key":"10.1016\/j.ram.2017.02.008_bib0275","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.abb.2009.07.011","article-title":"The Mycobacterium tuberculosis cytochrome P450 system","volume":"493","author":"Ouellet","year":"2010","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.ram.2017.02.008_bib0280","article-title":"Deletion of cyp125 Confers increased sensitivity to azoles in Mycobacterium tuberculosis","volume":"10:e0133129","author":"Parish","year":"2015","journal-title":"PLOS ONE"},{"key":"10.1016\/j.ram.2017.02.008_bib0285","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1128\/AAC.02154-12","article-title":"Activities of drug combinations against Mycobacterium tuberculosis grown in aerobic and hypoxic acidic conditions","volume":"57","author":"Piccaro","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ram.2017.02.008_bib0290","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2460\/javma.1985.187.04.405","article-title":"Efficacy of Ipronidazol against Trichomoniasis in beef bulls","volume":"187","author":"Skirrows","year":"1985","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.ram.2017.02.008_bib0295","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1093\/jac\/dkm207","article-title":"Resazurin reduction assay for screening of anti-tubercular compounds against dormant and actively growing M. tuberculosis, M. bovis BCG and M. smegmatis","volume":"60","author":"Taneja","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ram.2017.02.008_bib0300","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1128\/AAC.38.9.2054","article-title":"Metronidazole is bactericidal to dormant cells of M. tuberculosis","volume":"38","author":"Wayne","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ram.2017.02.008_bib0305","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1128\/IAI.64.6.2062-2069.1996","article-title":"An in vitro model for sequential study of shiftdown of Mycobacterium tuberculosis through two stages of nonreplicating persistence","volume":"64","author":"Wayne","year":"1996","journal-title":"Infect Immun"},{"key":"10.1016\/j.ram.2017.02.008_bib0310","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1751-0813.1987.tb09671.x","article-title":"Treatment of trichomoniasis","volume":"64","author":"Williams","year":"1987","journal-title":"Aust Vet J"},{"key":"10.1016\/j.ram.2017.02.008_bib0315","unstructured":"World Health Organization, Stop TB Partnertship 2011, The Global Plan to Stop TB."},{"key":"10.1016\/j.ram.2017.02.008_bib0320","unstructured":"World Health Organization. Global Tuberculosis Report 2013. Argentina. Perfil de Tuberculosis. www.who.int\/tb\/data."}],"container-title":["Revista Argentina de Microbiolog\u00eda"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0325754117300895?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0325754117300895?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T19:30:18Z","timestamp":1750879818000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0325754117300895"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S0325754117300895"],"URL":"https:\/\/doi.org\/10.1016\/j.ram.2017.02.008","relation":{},"ISSN":["0325-7541"],"issn-type":[{"value":"0325-7541","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro anti-tuberculosis activity of azole drugs against Mycobacterium tuberculosis clinical isolates","name":"articletitle","label":"Article Title"},{"value":"Revista Argentina de Microbiolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ram.2017.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Asociaci\u00f3n Argentina de Microbiolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}